Publication | Closed Access

Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome

Non-pharmacological InterventionHypertensionMarfan SyndromeRandomized Clinical TrialCardiovascular DiseaseAntihypertensive TherapyPharmacologyCardiovascular PharmacologyClinical TrialsPharmacotherapyMarfan SartanMedicine